Literature DB >> 18280241

Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport.

Sang-Oh Yoon1, Sejeong Shin, Yuzhen Liu, Bryan A Ballif, Michele S Woo, Steven P Gygi, John Blenis.   

Abstract

The major participants of the Ras/ERK and PI3-kinase (PI3K) pathways are well characterized. The cellular response to activation of these pathways, however, can vary dramatically. How differences in signal strength, timing, spatial location, and cellular context promote specific cell-fate decisions remains unclear. Nuclear transport processes can have a major impact on the determination of cell fate; however, little is known regarding how nuclear transport is regulated by or regulates these pathways. Here we show that RSK and Akt, which are activated downstream of Ras/ERK and PI3K, respectively, modulate the Ran gradient and nuclear transport by interacting with, phosphorylating, and regulating Ran-binding protein 3 (RanBP3) function. Our findings highlight an important link between two major cell-fate determinants: nuclear transport and the Ras/ERK/RSK and PI3K/Akt signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18280241      PMCID: PMC2266693          DOI: 10.1016/j.molcel.2007.12.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  37 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle.

Authors:  Karsten Weis
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

3.  Ran in the spindle checkpoint: a new function for a versatile GTPase.

Authors:  Hoi-Yeung Li; Kan Cao; Yixian Zheng
Journal:  Trends Cell Biol       Date:  2003-11       Impact factor: 20.808

Review 4.  The small GTPase Ran: interpreting the signs.

Authors:  B Booth Quimby; Mary Dasso
Journal:  Curr Opin Cell Biol       Date:  2003-06       Impact factor: 8.382

5.  Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization.

Authors:  Naoya Fujita; Saori Sato; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

Review 6.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

Review 7.  MAPK signal specificity: the right place at the right time.

Authors:  Leon O Murphy; John Blenis
Journal:  Trends Biochem Sci       Date:  2006-04-17       Impact factor: 13.807

Review 8.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

Review 9.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

10.  The tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells.

Authors:  Robert A Cartlidge; Axel Knebel; Mark Peggie; Andrei Alexandrov; Eric M Phizicky; Philip Cohen
Journal:  EMBO J       Date:  2005-04-14       Impact factor: 11.598

View more
  45 in total

1.  PPM1A dephosphorylates RanBP3 to enable efficient nuclear export of Smad2 and Smad3.

Authors:  Fangyan Dai; Tao Shen; Zhaoyong Li; Xia Lin; Xin-Hua Feng
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

2.  Nuclear Export of Smads by RanBP3L Regulates Bone Morphogenetic Protein Signaling and Mesenchymal Stem Cell Differentiation.

Authors:  Fenfang Chen; Xia Lin; Pinglong Xu; Zhengmao Zhang; Yanzhen Chen; Chao Wang; Jiahuai Han; Bin Zhao; Mu Xiao; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2015-03-09       Impact factor: 4.272

3.  Phosphorylation of Ran-binding protein-1 by Polo-like kinase-1 is required for interaction with Ran and early mitotic progression.

Authors:  Hyo-In Hwang; Jae-Hoon Ji; Young-Joo Jang
Journal:  J Biol Chem       Date:  2011-08-03       Impact factor: 5.157

4.  Traffic control at the nuclear pore.

Authors:  Mohamed Kodiha; Noah Crampton; Sanhita Shrivastava; Rehan Umar; Ursula Stochaj
Journal:  Nucleus       Date:  2010-02-08       Impact factor: 4.197

5.  Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication.

Authors:  Naveen Kumar; Yuhong Liang; Tristram G Parslow; Yuying Liang
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

6.  Intracellular Ca2+ Homeostasis and Nuclear Export Mediate Exit from Naive Pluripotency.

Authors:  Matthew S MacDougall; Ryan Clarke; Bradley J Merrill
Journal:  Cell Stem Cell       Date:  2019-05-16       Impact factor: 24.633

7.  A high-throughput, cell-based screening method for siRNA and small molecule inhibitors of mTORC1 signaling using the In Cell Western technique.

Authors:  Gregory R Hoffman; Nathan J Moerke; Max Hsia; Caroline E Shamu; John Blenis
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

8.  Gene expression responses in male fathead minnows exposed to binary mixtures of an estrogen and antiestrogen.

Authors:  Natàlia Garcia-Reyero; Kevin J Kroll; Li Liu; Edward F Orlando; Karen H Watanabe; María S Sepúlveda; Daniel L Villeneuve; Edward J Perkins; Gerald T Ankley; Nancy D Denslow
Journal:  BMC Genomics       Date:  2009-07-13       Impact factor: 3.969

9.  Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.

Authors:  Moritz Hentschke; Laura Berneking; Cristina Belmar Campos; Friedrich Buck; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

10.  Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors.

Authors:  Mohamed Kodiha; Dan Tran; Andreea Morogan; Cynthia Qian; Ursula Stochaj
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.